Enhanced Pathogenic Consequences Induced by a Seven-Amino-Acid Extension in the G Protein of the HRSV BA9 Genotype., PMID:40076707
Evidence that the cell glycocalyx envelops respiratory syncytial virus (RSV) particles that form on the surface of RSV-infected human airway cells., PMID:40044247
The recent landscape of RSV vaccine research., PMID:39802673
Molecular features of the serological IgG repertoire elicited by egg-based, cell-based, or recombinant haemagglutinin-based seasonal influenza vaccines: a comparative, prospective, observational cohort study., PMID:39667375
A potently neutralizing and protective human antibody targeting antigenic site V on RSV and hMPV fusion glycoprotein., PMID:39554078
MHC class I and II-deficient humanized mice are suitable tools to test the long-term antitumor efficacy of immune checkpoint inhibitors and T-cell engagers., PMID:39244214
Differences Between RSV A and RSV B Subgroups and Implications for Pharmaceutical Preventive Measures., PMID:38971918
Genetic characterization of respiratory syncytial virus surface glycoproteins F and G in Taiwan, 2017-2021., PMID:38937186
Production and Immunogenicity of FeLV Gag-Based VLPs Exposing a Stabilized FeLV Envelope Glycoprotein., PMID:38932278
Intranasal Vaccination with a Respiratory-Syncytial-Virus-Based Virus-like Particle Displaying the G Protein Conserved Region Induces Severe Weight Loss and Pathology upon Challenge with Wildtype Respiratory Syncytial Virus., PMID:38932136
Respiratory syncytial virus entry mechanism in host cells: A general overview., PMID:37537859
Virus-like Particle Vaccine Expressing the Respiratory Syncytial Virus Pre-Fusion and G Proteins Confers Protection against RSV Challenge Infection., PMID:36986643
Antibody Correlates of Protection From Severe Respiratory Syncytial Virus Disease in a Vaccine Efficacy Trial., PMID:36655191
An RSV Live-Attenuated Vaccine Candidate Lacking G Protein Mucin Domains Is Attenuated, Immunogenic, and Effective in Preventing RSV in BALB/c Mice., PMID:36281651
Profiling of hMPV F-specific antibodies isolated from human memory B cells., PMID:35538099
Combinatorial F-G Immunogens as Nipah and Respiratory Syncytial Virus Vaccine Candidates., PMID:34696372
Humoral and Mucosal Antibody Response to RSV Structural Proteins in RSV-Infected Adult Hematopoietic Cell Transplant (HCT) Recipients., PMID:34073490
CX3CR1 Is a Receptor for Human Respiratory Syncytial Virus in Cotton Rats., PMID:34037420
Respiratory Syncytial Virus (RSV) G Protein Vaccines With Central Conserved Domain Mutations Induce CX3C-CX3CR1 Blocking Antibodies., PMID:33672319
Immunogenicity and inflammatory properties of respiratory syncytial virus attachment G protein in cotton rats., PMID:33600439
Mucosal Delivery of Recombinant Vesicular Stomatitis Virus Vectors Expressing Envelope Proteins of Respiratory Syncytial Virus Induces Protective Immunity in Cotton Rats., PMID:33408176
A Novel Live Attenuated Respiratory Syncytial Virus Vaccine Candidate with Mutations in the L Protein SAM Binding Site and the G Protein Cleavage Site Is Protective in Cotton Rats and a Rhesus Macaque., PMID:33177201
Features of the Human Antibody Response against the Respiratory Syncytial Virus Surface Glycoprotein G., PMID:32630611
Autoantibodies against the prion protein in individuals with PRNP mutations., PMID:32098855
Conformational Flexibility in Respiratory Syncytial Virus G Neutralizing Epitopes., PMID:31852779
Antigenic Fingerprinting of Respiratory Syncytial Virus (RSV)-A-Infected Hematopoietic Cell Transplant Recipients Reveals Importance of Mucosal Anti-RSV G Antibodies in Control of RSV Infection in Humans., PMID:31745552
Transient opening of trimeric prefusion RSV F proteins., PMID:31068578
Effects of Alterations to the CX3C Motif and Secreted Form of Human Respiratory Syncytial Virus (RSV) G Protein on Immune Responses to a Parainfluenza Virus Vector Expressing the RSV G Protein., PMID:30651356
Protective antigenic sites in respiratory syncytial virus G attachment protein outside the central conserved and cysteine noose domains., PMID:30142227
Development of a Virosomal RSV Vaccine Containing 3D-PHAD® Adjuvant: Formulation, Composition, and Long-Term Stability., PMID:29971500
Human respiratory syncytial virus: pathogenesis, immune responses, and current vaccine approaches., PMID:29876771
Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model., PMID:29765035
Structures of respiratory syncytial virus G antigen bound to broadly neutralizing antibodies., PMID:29523582
Structural basis for recognition of the central conserved region of RSV G by neutralizing human antibodies., PMID:29509814
Protection induced by virus-like particle vaccine containing tandem repeat gene of respiratory syncytial virus G protein., PMID:29338045
Evaluation of truncated G protein delivered by live attenuated Salmonella as a vaccine against respiratory syncytial virus., PMID:29306006
Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein., PMID:29187732
Antibody-Induced Internalization of the Human Respiratory Syncytial Virus Fusion Protein., PMID:28468888
A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge., PMID:28298602
Preclinical evaluation of bacterially produced RSV-G protein vaccine: Strong protection against RSV challenge in cotton rat model., PMID:28186208
Virus-like particle vaccines containing F or F and G proteins confer protection against respiratory syncytial virus without pulmonary inflammation in cotton rats., PMID:28129031
Secretory Expression and Purification of Respiratory Syncytial Virus G and F Proteins in Human Cells., PMID:27464687
Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease., PMID:27123586
Antigenic Fingerprinting following Primary RSV Infection in Young Children Identifies Novel Antigenic Sites and Reveals Unlinked Evolution of Human Antibody Repertoires to Fusion and Attachment Glycoproteins., PMID:27100289
Characterization of Epitope-Specific Anti-Respiratory Syncytial Virus (Anti-RSV) Antibody Responses after Natural Infection and after Vaccination with Formalin-Inactivated RSV., PMID:27099320
Development of Electrochemiluminescent Serology Assays to Measure the Humoral Response to Antigens of Respiratory Syncytial Virus., PMID:27070145
Cell fusion assay by expression of respiratory syncytial virus (RSV) fusion protein to analyze the mutation of palivizumab-resistant strains., PMID:26794681
Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures., PMID:26658574
CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells., PMID:26297201
CX3CR1 Is Expressed in Differentiated Human Ciliated Airway Cells and Co-Localizes with Respiratory Syncytial Virus on Cilia in a G Protein-Dependent Manner., PMID:26107373
For research use only. Not for human or drug use.
